BioNexus Gene Lab Corp. (BGLC)

USD 0.26

(-2.99%)

Gross Profit Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual gross profit in 2023 was 1.32 Million USD , up 5.6% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly gross profit in 2024 Q2 was 268.51 Thousand USD , down -16.29% from previous quarter.
  • BioNexus Gene Lab Corp. reported a annual gross profit of 1.25 Million USD in annual gross profit 2022, down -42.61% from previous year.
  • BioNexus Gene Lab Corp. reported a annual gross profit of 2.19 Million USD in annual gross profit 2021, up 27.56% from previous year.
  • BioNexus Gene Lab Corp. reported a quarterly gross profit of 344.89 Thousand USD for 2024 Q1, up 29.39% from previous quarter.
  • BioNexus Gene Lab Corp. reported a quarterly gross profit of 354.33 Thousand USD for 2023 Q3, up 4.3% from previous quarter.

Annual Gross Profit Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Gross Profit of BioNexus Gene Lab Corp. (2023 - 2016)

Year Gross Profit Gross Profit Growth
2023 1.32 Million USD 5.6%
2022 1.25 Million USD -42.61%
2021 2.19 Million USD 27.56%
2020 1.71 Million USD 2977.27%
2019 55.88 Thousand USD 94.29%
2018 28.76 Thousand USD -63.5%
2017 78.8 Thousand USD 0.0%
2016 - USD 0.0%

Peer Gross Profit Comparison of BioNexus Gene Lab Corp.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 86.102%
Prenetics Global Limited 8.82 Million USD 84.943%
Star Equity Holdings, Inc. 11.92 Million USD 88.852%
CareDx, Inc 178.32 Million USD 99.254%
Exact Sciences Corporation 1.84 Billion USD 99.928%
Exagen Inc. 29.45 Million USD 95.486%
Inotiv, Inc. 165.44 Million USD 99.196%
Guardant Health, Inc. 336.89 Million USD 99.605%
Biodesix, Inc. 36.07 Million USD 96.315%
Precipio, Inc. 6.01 Million USD 77.908%
iSpecimen Inc. 5.1 Million USD 73.972%
Natera, Inc. 492.74 Million USD 99.73%
Aspira Women's Health Inc. 5.26 Million USD 74.734%
Standard BioTools Inc. 50.45 Million USD 97.365%
23andMe Holding Co. 99.37 Million USD 98.662%
Castle Biosciences, Inc. 174.8 Million USD 99.239%
Personalis, Inc. 18.2 Million USD 92.698%
Aclaris Therapeutics, Inc. 13.16 Million USD 89.904%
Applied DNA Sciences, Inc. 5.53 Million USD 75.973%
OpGen, Inc. -90.69 Thousand USD 1565.916%
T2 Biosystems, Inc. -8.17 Million USD 116.273%
Myriad Genetics, Inc. 476.4 Million USD 99.721%
ICON Public Limited Company 1.81 Billion USD 99.927%
NeoGenomics, Inc. 244.6 Million USD 99.456%
Star Equity Holdings, Inc. 11.92 Million USD 88.852%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.939%
RadNet, Inc. 93 Million USD 98.57%
MDxHealth SA 43.92 Million USD 96.974%
Psychemedics Corporation 8.41 Million USD 84.197%
Illumina, Inc. 2.74 Billion USD 99.952%
Check-Cap Ltd. -212 Thousand USD 727.122%
Twist Bioscience Corporation 133.34 Million USD 99.003%
DarioHealth Corp. 5.98 Million USD 77.782%
Fulgent Genetics, Inc. 104.45 Million USD 98.727%
Sera Prognostics, Inc. 96 Thousand USD -1284.894%
ENDRA Life Sciences Inc. -275.45 Thousand USD 582.662%
OPKO Health, Inc. 318.12 Million USD 99.582%
Medpace Holdings, Inc. 524.5 Million USD 99.747%
Neogen Corporation 463.9 Million USD 99.713%
Intelligent Bio Solutions Inc. 1.42 Million USD 6.743%
Prenetics Global Limited 8.82 Million USD 84.943%
Mainz Biomed B.V. 509.65 Thousand USD -160.86%
bioAffinity Technologies, Inc. 791.61 Thousand USD -67.948%
Trinity Biotech plc 19.45 Million USD 93.165%
Neuronetics, Inc. 51.7 Million USD 97.429%
Sotera Health Company 577.15 Million USD 99.77%
bioAffinity Technologies, Inc. 791.61 Thousand USD -67.948%